£107.98

Humana Cancer of the Lung: From Molecular Biology to Treatment Guidelines (Current Clinical Oncology)

Price data checked 1 day ago

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£108 today · previous high £108 · all-time low £107

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 90 days • 90 data points

Historical
Generating forecast...
£107.98 £107.20 £107.37 £107.54 £107.71 £107.88 £108.05 18 February 2026 12 March 2026 03 April 2026 25 April 2026 18 May 2026

Price Distribution

Price distribution over 90 days • 2 price levels

Days at Price
Current Price
71 days 19 days · current 0 18 36 53 71 £107 £108 Days at Price

Price Analysis

Most common price: £107 (71 days, 78.9%)

Price range: £107 - £108

Price levels: 2 different prices over 90 days

Description

Alan B. Weitberg, MD, and a panel of internationally recognized basic scientists and clinicians present a comprehensive discussion of lung cancer, including a practice-oriented review of its diagnosis, evaluation, and treatment. The contributors offer not only an understandable description of its molecular origins-an essential key to developing future therapies and preventive measures-but also rigorously discuss well-tested approaches, as well as those that are currently being evaluated for future use in both the laboratory and clinic. The book also elucidates the creation and effective deployment of treatment guidelines introduced by third party payers to improve clinical outcomes, even while lowering healthcare costs.

Product Specifications

Brand
Humana
Format
paperback
Domain
Amazon UK
Release Date
19 November 2010
Listed Since
01 October 2010

Barcode

No barcode data available

Similar Products You Might Like

Non-Small Cell Lung Cancer: New Research (Cancer Etiology, Diagnosis and Treatments)
84% match

Non-Small Cell Lung Cancer: New Research (Cancer Etiology, Diagnosis and Treatments)

£65.70 04 May 2026
Molecular Targeting in Oncology (Cancer Drug Discovery and Development)
84% match

Molecular Targeting in Oncology (Cancer Drug Discovery and Development)

Humana

£148.05 18 May 2026
Pancreatic Cancer: Pathogenesis, Diagnosis, and Treatment
84% match

Pancreatic Cancer: Pathogenesis, Diagnosis, and Treatment

Humana

£77.50 18 May 2026
Management of Lung Cancer in Older People
83% match

Management of Lung Cancer in Older People

Springer

£103.24 18 May 2026
Bladder Cancer: Diagnosis, Therapeutics, and Management (Current Clinical Urology)
83% match

Bladder Cancer: Diagnosis, Therapeutics, and Management (Current Clinical Urology)

Humana

£80.65 11 May 2026
Lung Cancer Metastasis: Novel Biological Mechanisms and Impact on Clinical Practice
83% match

Lung Cancer Metastasis: Novel Biological Mechanisms and Impact on Clinical Practice

Springer

£80.64 18 May 2026
Insulin-like Growth Factors and Cancer: From Basic Biology to Therapeutics (Cancer Drug Discovery and Development)
83% match

Insulin-like Growth Factors and Cancer: From Basic Biology to Therapeutics (Cancer Drug Discovery and Development)

Humana

£107.57 18 May 2026
Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval (Cancer Drug Discovery and Development)
82% match

Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval (Cancer Drug Discovery and Development)

Humana

£77.90 18 May 2026
Chronic Obstructive Pulmonary Disease: Co-Morbidities and Systemic Consequences (Respiratory Medicine)
82% match

Chronic Obstructive Pulmonary Disease: Co-Morbidities and Systemic Consequences (Respiratory Medicine)

Humana

£80.64 11 May 2026
Advances in DNA Repair in Cancer Therapy (Cancer Drug Discovery and Development)
81% match

Advances in DNA Repair in Cancer Therapy (Cancer Drug Discovery and Development)

Humana

£142.42 18 May 2026
Nuclear Signaling Pathways and Targeting Transcription in Cancer (Cancer Drug Discovery and Development)
81% match

Nuclear Signaling Pathways and Targeting Transcription in Cancer (Cancer Drug Discovery and Development)

Humana

£110.39 18 May 2026
Management of Lung Cancer in Older People
81% match

Management of Lung Cancer in Older People

Springer

£80.64 11 May 2026
Obesity and Lung Disease: A Guide to Pathophysiology, Evaluation, and Management (Respiratory Medicine)
81% match

Obesity and Lung Disease: A Guide to Pathophysiology, Evaluation, and Management (Respiratory Medicine)

Humana

£80.64 04 May 2026
Progress and Perspective in the Treatment of Lung Cancer (Medical Radiology)
81% match

Progress and Perspective in the Treatment of Lung Cancer (Medical Radiology)

Springer

£107.98 18 May 2026
Non-Hodgkin Lymphoma: Prognostic Factors and Targets (Cancer Drug Discovery and Development)
81% match

Non-Hodgkin Lymphoma: Prognostic Factors and Targets (Cancer Drug Discovery and Development)

Humana

£107.98 18 May 2026
In Vivo Imaging of Cancer Therapy (Cancer Drug Discovery and Development)
80% match

In Vivo Imaging of Cancer Therapy (Cancer Drug Discovery and Development)

Humana

£80.65 19 May 2026
Clinical Ophthalmic Oncology: Retinoblastoma
80% match

Clinical Ophthalmic Oncology: Retinoblastoma

Springer

£70.21 04 May 2026
Molecular Oncology: Underlying Mechanisms and Translational Advancements
80% match

Molecular Oncology: Underlying Mechanisms and Translational Advancements

Springer

£80.64 17 May 2026
Integrative Therapies in Lung Health and Sleep: 4 (Respiratory Medicine)
80% match

Integrative Therapies in Lung Health and Sleep: 4 (Respiratory Medicine)

Humana

£80.64 11 May 2026
Colorectal Cancer: Evidence-based Chemotherapy Strategies (Current Clinical Oncology)
80% match

Colorectal Cancer: Evidence-based Chemotherapy Strategies (Current Clinical Oncology)

Humana

£40.30 04 May 2026
Chronic Leukemias and Lymphomas: Biology, Pathophysiology, and Clinical Management (Current Clinical Oncology)
80% match

Chronic Leukemias and Lymphomas: Biology, Pathophysiology, and Clinical Management (Current Clinical Oncology)

Humana

£80.64 18 May 2026
Drug Resistance in Cancer Therapy: 48 (Cancer Treatment and Research, 48)
80% match

Drug Resistance in Cancer Therapy: 48 (Cancer Treatment and Research, 48)

Springer

£113.76 18 May 2026
Gene Therapy of Solid Cancers: Methods and Protocols: 1317 (Methods in Molecular Biology, 1317)
80% match

Gene Therapy of Solid Cancers: Methods and Protocols: 1317 (Methods in Molecular Biology, 1317)

Humana

£73.56 18 May 2026
Nucleic Acid Therapeutics in Cancer (Cancer Drug Discovery and Development)
80% match

Nucleic Acid Therapeutics in Cancer (Cancer Drug Discovery and Development)

Humana

£73.10 18 May 2026